Financial Times featured Tucuvi’s collaboration with AstraZeneca to support Vall d'Hebron Barcelona Hospital in advancing patient care.

In an article for the Financial Times, Sarah Neville highlights Tucuvi’s collaboration with AstraZeneca to support Vall d'Hebron Barcelona Hospital Campus in advancing patient care.

Through Tucuvi’s clinical virtual assistant, LOLA, the hospital has enhanced early detection of symptom worsening in patients with Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD).

By leveraging Tucuvi’s Clinical Conversational AI, Vall d'Hebron has significantly improved its ability to deliver high-quality care. The hospital has seen notable increases in clinical team efficiency and patient outcomes, as well as providing personalized support to those who need it most.

Check out the full article here

Tucuvi:
Clinically Validated
AI for Healthcare

Book a demo